Penederm
This article was originally published in The Tan Sheet
Executive Summary
President Lloyd Malchow appointed CEO, effective Jan. 1. Malchow, 40, succeeds current Chairman and CEO Harris Goodman, 57, who is retiring from the company. Terry Opdendyk, a member of the Penederm board, will assume the position of chairman. Penederm also announced Dec. 6 that former Schering-Plough HealthCare President and corporate Exec VP David Collins has joined the company's board of directors
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning